These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27252534)

  • 1. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
    Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
    J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
    Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
    Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
    Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion.
    Wu G; Yu G; Yu Y; Yang S; Duan Z; Wang W; Liu Y; Yu R; Li J; Zhu T; Gu Q; Li D
    J Med Chem; 2020 Jul; 63(13):6924-6940. PubMed ID: 32520560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.
    Yan D; Krumm SA; Sun A; Steinhauer DA; Luo M; Moore ML; Plemper RK
    J Virol; 2013 Oct; 87(20):11076-87. PubMed ID: 23926334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins.
    Du R; Cheng H; Cui Q; Peet NP; Gaisina IN; Rong L
    Antiviral Res; 2021 Feb; 186():105013. PubMed ID: 33428962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
    Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
    J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A virus entry inhibitors targeting the hemagglutinin.
    Yang J; Li M; Shen X; Liu S
    Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Yao Y; Kadam RU; Lee CD; Woehl JL; Wu NC; Zhu X; Kitamura S; Wilson IA; Wolan DW
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18431-18438. PubMed ID: 32690700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the Affimer platform against influenza A virus.
    Debski-Antoniak O; Flynn A; Klebl DP; Rojas Rechy MH; Tiede C; Wilson IA; Muench SP; Tomlinson D; Fontana J
    mBio; 2024 Aug; 15(8):e0180424. PubMed ID: 39037231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.
    Du Pont V; Wirblich C; Yoon JJ; Cox RM; Schnell MJ; Plemper RK
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
    Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
    J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
    Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics.
    Lai KK; Cheung NN; Yang F; Dai J; Liu L; Chen Z; Sze KH; Chen H; Yuen KY; Kao RY
    J Virol; 2015 Dec; 90(5):2690-701. PubMed ID: 26676787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus.
    Hussein AFA; Cheng H; Tundup S; Antanasijevic A; Varhegyi E; Perez J; AbdulRahman EM; Elenany MG; Helal S; Caffrey M; Peet N; Manicassamy B; Rong L
    Antiviral Res; 2020 May; 177():104782. PubMed ID: 32222293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
    Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
    PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolidase is required for early trafficking events during influenza A virus entry.
    Pohl MO; Edinger TO; Stertz S
    J Virol; 2014 Oct; 88(19):11271-83. PubMed ID: 25031340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence polarization-based assay using N-glycan-conjugated quantum dots for screening in hemagglutinin blockers for influenza A viruses.
    Okamatsu M; Feng F; Ohyanagi T; Nagahori N; Someya K; Sakoda Y; Miura N; Nishimura S; Kida H
    J Virol Methods; 2013 Feb; 187(2):390-4. PubMed ID: 23164994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
    Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.